Volume 29, Issue 137 (November & December 2021)                   J Adv Med Biomed Res 2021, 29(137): 324-330 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Abdollahzade Fard A, Saboory E, Biabangard A, Amini M. S-Allyl Cysteine Mitigates Kidney Dysfunctions in the Rat Models of Preeclampsia and Eclampsia: The Possible Role of TNF-α and IL1-β. J Adv Med Biomed Res 2021; 29 (137) :324-330
URL: http://journal.zums.ac.ir/article-1-6182-en.html
S-Allyl Cysteine Mitigates Kidney Dysfunctions in the Rat Models of Preeclampsia and Eclampsia: The Possible Role of TNF-α and IL1-β
Amin Abdollahzade Fard1 , Ehsan Saboory * 2, Abdolrahman Biabangard3 , Mohammad Amini3
1- Nephrology and Kidney Transplant Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran
2- Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran , saboory@zums.ac.ir
3- Dept. of Physiology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
Abstract:   (120076 Views)

Background and Objective: Preeclampsia (PE) is a pregnancy complication with the signs of kidney damage. The effect of S-Allyl-cysteine (SAC) on inflammatory cytokines was evaluated to prevent PE-induced renal complications.
Materials and Methods: Wistar rats were divided into seven groups: 1) control, 2) PE, 3) EC, 4) PE+SAC50, 5) PE+SAC200, 6) EC+SAC50, and 7) EC+SAC200. In Groups 1-3, the rats received saline by gavage for 9 consecutive days, starting on the day 11 of gestation (G11). In Groups 4-7, the rats received SAC (50 or 200mg/kg) by gavage for 9 days, starting on G11. The rats in PE and EC groups were injected with Lipopolysaccharides on G14. The rats in EC groups were injected with pentylenetetrazol (PTZ) on G16 and G18. On G20, urine, blood, and kidney samples were collected for biochemical analysis.
Results: In PE and EC groups, creatinine clearance, urine protein/creatinine ratio and proteinuria significantly increased compared to the control rats. Administration of SAC significantly reduced protein excretion and the protein/creatinine ratio in the urine specimen of all treated groups.
The results showed significant increase in the renal concentration of IL-1β and TNF-α in the PE and EC rats. Administration of 200 mg/kg SAC significantly decreased IL-1β and TNF-α in all treated groups. SAC (200mg/kg) significantly decreased malondialdehyde and ameliorated histological changes in PE and EC groups; it also mitigated kidney dysfunctions in experimental PE and EC.
Conclusion: The ameliorative effect of SAC may be mediated by its antioxidant and modulatory effects on cytokines, such as IL-1β and TNF-α.

Keywords: S-allyl cysteine, TNF-α, IL-1β, Kidney, Ppreeclampsia
Full-Text [PDF 602 kb]   (117970 Downloads) |   |   Full-Text (HTML)  (2037 Views)  

✅ The ameliorative effect of SAC may be mediated by its antioxidant and modulatory effects on cytokines, such as IL-1β and TNF-α.


Type of Study: Original Article | Subject: Medical Biology
Received: 2020/11/22 | Accepted: 2021/06/1 | Published: 2021/08/1
References
1. Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, VP. S. Pre‐eclampsia: A renal perspective. Kidney Int. 2005;67:2101-13. [DOI:10.1111/j.1523-1755.2005.00316.x]
2. Piccoli GB, Mannucci C. Preeclampsia: A diagnosis-nondiagnosis that is too easily made: The case of primary hyperaldosteronism. Kidney Blood Pressure Res. 2020;45(3):363-7. [DOI:10.1159/000507116]
3. Zelinka T, Petrák O, Rosa J, Holaj R, Štrauch B, Widimský J. Primary aldosteronism and pregnancy. Kidney Blood Pressure Res. 2020;45(2):275-85. [DOI:10.1159/000506287]
4. Lewis DF, Canzoneri BJ, Wang Y. Maternal circulating TNF‐α levels are highly correlated with IL‐10 levels, but not IL‐6 and IL‐8 Levels, in Women with Pre‐Eclampsia. Am J Reprod Immunol. 2009;62(5):269-74. [DOI:10.1111/j.1600-0897.2009.00735.x]
5. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Obstet Gynecol. 2000;95(1):24-8. [DOI:10.1016/S0029-7844(99)00462-7]
6. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994;170(6):1752-9. [DOI:10.1016/S0002-9378(94)70351-5]
7. Tosun M, Celik H, Avci B, Yavuz E, Alper T, Malatyalioğlu E. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-α in normal pregnancies and in pregnancies complicated by preeclampsia. J Matern Fetal Neonatal Med. 2010;23(8):880-6. [DOI:10.3109/14767051003774942]
8. Peraçoli JC, Rudge MVC, Peraçoli MTS. Tumor necrosis factor‐alpha in gestation and puerperium of women with gestational hypertension and pre‐eclampsia. Am J Reprod Immunol 2007;57(3):177-85. [DOI:10.1111/j.1600-0897.2006.00455.x]
9. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294(2):H541-H50. [DOI:10.1152/ajpheart.01113.2007]
10. Polyzos NP, Mauri D, Tsappi M, et al. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv. 2007;62(3):202-6. [DOI:10.1097/01.ogx.0000256787.04807.da]
11. Patel M, Sachan R, Gangwar R, Sachan P, Natu S. Correlation of serum neutrophil gelatinase-associated lipocalin with acute kidney injury in hypertensive disorders of pregnancy. Int J Nephrol Renovasc Dis. 2013;6:181-6. [DOI:10.2147/IJNRD.S45523]
12. Numagami Y, Ohnishi ST. S-allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia. J Nutr. 2001;131(3):1100S-5S. [DOI:10.1093/jn/131.3.1100S]
13. Maldonado PD, Barrera D, Rivero I, et al. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free Radic Biol Med 2003;35(3):317-24. [DOI:10.1016/S0891-5849(03)00312-5]
14. Hsu CC, Lin CC, Liao TS, Yin MC. Protective effect of s-allyl cysteine and s-propyl cysteine on acetaminophen-induced hepatotoxicity in mice. Food Chem Toxicol. 2006;44(3):393-7. [DOI:10.1016/j.fct.2005.08.012]
15. Mostafa MG, Mima T, Ohnishi ST, Mori K. S-allylcysteine ameliorates doxorubicin toxicity in the heart and liver in mice. Planta Medica. 2000;66(02):148-51. [DOI:10.1055/s-2000-11124]
16. Kabasakal L, Şehirli Ö, Çetinel Ş, Cikler E, Gedik N, Şener G. Protective effect of aqueous garlic extract against renal ischemia/reperfusion injury in rats. J Med Food 2005;8(3):319-26. [DOI:10.1089/jmf.2005.8.319]
17. Huang Q, Liu L, Hu B, Di X, Brennecke SP, Liu H. Decreased seizure threshold in an eclampsia-like model induced in pregnant rats with lipopolysaccharide and pentylenetetrazol treatments. PLoS One. 2014;9(2):e89333-e. [DOI:10.1371/journal.pone.0089333]
18. Müller K, Brunnberg L. Determination of plasma albumin concentration in healthy and diseased turtles: A comparison of protein electrophoresis and the bromcresol green dye-binding method. Vet Clin Pathol 2009;39:79-82. [DOI:10.1111/j.1939-165X.2009.00177.x]
19. Chan P, Brown M, Simpson JM, Davis G. Proteinuria in pre‐eclampsia: how much matters? An Int J Obstet Gynaecol. 2005;112(3):280-5. [DOI:10.1111/j.1471-0528.2004.00395.x]
20. Demirci O, Kumru P, Arınkan A, et al. Spot protein/creatinine ratio in preeclampsia as an alternative for 24-hour urine protein. Balkan Med J. 2015;32(1):51. [DOI:10.5152/balkanmedj.2015.15447]
21. Cackovic M, Buhimschi CS, Zhao G, et al. Fractional excretion of tumor necrosis factor-α in women with severe preeclampsia. Obstet Gynecol. 2008;112(1):93. [DOI:10.1097/AOG.0b013e31817c4304]
22. Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am. 2010;37(2):239-53. [DOI:10.1016/j.ogc.2010.02.013]
23. Rusterholz C, Hahn S, Holzgreve W. Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol 2007;29(2):151-62. [DOI:10.1007/s00281-007-0071-6]
24. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab. 1997;82(5):1582-8. [DOI:10.1210/jc.82.5.1582]
25. Hayashi M, Ueda Y, Yamaguchi T, et al. Tumor necrosis factor‐α in the placenta is not elevated in pre‐eclamptic patients despite its elevation in peripheral blood. Am J Reprod Immunol. 2005;53(3):113-9. [DOI:10.1111/j.1600-0897.2005.00253.x]
26. Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20(2):87-103. [DOI:10.1615/CritRevEukarGeneExpr.v20.i2.10]
27. Xu C, Wu X, Hack BK, Bao L, Cunningham PN. TNF causes changes in glomerular endothelial permeability and morphology through a Rho and myosin light chain kinase-dependent mechanism. Physiol Rep. 2015;3(12):e12636. [DOI:10.14814/phy2.12636]
28. Neale TJ, Rüger BM, Macaulay H, et al. Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am J Pathol. 1995;146(6):1444-54.
29. Visser N, van Rijn BB, Rijkers GT, Franx A, Bruinse HW. Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv. 2007;62(3):191-201. [DOI:10.1097/01.ogx.0000256779.06275.c4]
30. Kalinderis M, Papanikolaou A, Kalinderi K, et al. Elevated serum levels of interleukin‐6, interleukin‐1β and human chorionic gonadotropin in pre‐eclampsia. Am J Reprod Immunol. 2011;66(6):468-75. [DOI:10.1111/j.1600-0897.2011.01019.x]
31. Niemir ZI, Stein H, Dworacki G, et al. Podocytes are the major source of IL-1α and IL-1β in human glomerulonephritides. Kidney Int. 1997;52(2):393-403. [DOI:10.1038/ki.1997.346]
32. Zhang W, Li Q, Wang L, Yang X. Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats. Pediatr Nephrol. 2008;23(12):2185-94. [DOI:10.1007/s00467-008-0933-8]
33. Khajevand-Khazaei M-R, Azimi S, Sedighnejad L, Salari S, Ghorbanpour A, Baluchnejadmojarad T, et al. S-allyl cysteine protects against lipopolysaccharide-induced acute kidney injury in the C57BL/6 mouse strain: Involvement of oxidative stress and inflammation. Int Immunopharmaco. 2019;69:19-26. [DOI:10.1016/j.intimp.2019.01.026]
34. Magendiramani V, Umesalma S, Kalayarasan S, Nagendraprabhu P, Arunkumar J, Sudhandiran G. S‐allylcysteine attenuates renal injury by altering the expressions of iNOS and matrix metallo proteinase‐2 during cyclosporine‐induced nephrotoxicity in Wistar rats. J Appl Toxicol 2009;29(6):522-30. [DOI:10.1002/jat.1437]
35. Segoviano‐Murillo S, Sánchez‐González DJ, Martínez‐Martínez CM, Cruz C, Maldonado PD, Pedraza‐Chaverrí J. S‐allylcysteine ameliorates ischemia and reperfusion induced renal damage. Phytother Res. 2008;22(6):836-40. [DOI:10.1002/ptr.2396]
36. Faas MM, Schuiling GA, Linton EA, Sargent IL, Redman CW. Activation of peripheral leukocytes in rat pregnancy and experimental preeclampsia. Am J Obstet Gynecol. 2000;182(2):351-7. [DOI:10.1016/S0002-9378(00)70223-7]
37. Ide N, Lau BH. Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-κB activation. J Nutr. 2001;131(3):1020S-6S. [DOI:10.1093/jn/131.3.1020S]
38. Stark J. Pre‐eclampsia and cytokine induced oxidative stress. An Int J Obstet Gynaecol. 1993;100(2):105-9. [DOI:10.1111/j.1471-0528.1993.tb15203.x]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb